Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (194)	1/13/2003 4:06:21 PM
From: Jibacoa	Respond to of 3722

IMPH Has had a 100% gain from its Sept.2002 L, but it is still 50% below its March 2002 H.<g> Today it is up 9.20% on volume of 406,330 which is about 1.5x its daily average. IMPH announced last week an agreement with ADCS, (a division of Ortho, which is a division of JNJ <g>) and Immunicon Corp., (a private biomedical company) IMPH will use Immunicon's technology for the analysis of circulating tumor cells. The stock closed on a little down-tick.<g> siliconinvestor.com But it closed at its highest level since July.<g>It still needs to close above its May-June resistance at the 23.50 to 24 level, before it can test its March 2002 H at 44.40 siliconinvestor.com Bernard